跳轉至內容
Merck
全部照片(2)

Key Documents

HAGP1MAG-12K

Millipore

MILLIPLEX® 人血管生成/生长因子磁珠板 - 癌症多重检测

Angiogenesie Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple angiogenic biomarkers in human serum, plasma and cell culture samples.

同義詞:

human oncology growth factor immunoassay panel, luminex human cancer angiogenesis growth factor multiplex assay, millipore human cancer growth factor protein multiplex kit

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12161503
eCl@ss:
32161000
NACRES:
NA.84

品質等級

物種活性

human

製造商/商標名

Milliplex®

assay range

accuracy: 42-131%
standard curve range: 1.4-1,000 pg/mL
(HB-EGF, IL-8, PLGF)

standard curve range: 13.7-10,000 pg/mL
(Angiopoietin-2, FGF-1, FGF-2, G-CSF, VEGF-A)

standard curve range: 137.2-100,000 pg/mL
(Leptin)

standard curve range: 2.7-2,000 pg/mL
(BMP-9, EGF, Endothelin-1)

standard curve range: 27.4-20,000 pg/mL
(Endoglin, Follistatin, HGF)

standard curve range: 6.9-5,000 pg/mL
(VEGF-C, VEGF-D)

技術

multiplexing: suitable

檢測方法

fluorometric (Luminex xMAP)

運輸包裝

wet ice

一般說明

血管生成是新血管网的发展,是正常生长和发育以及伤口愈合的关键过程,其动态平衡由血管生成因子和抑制剂的精细平衡维持。因此,血管生长不足或过度是许多疾病的基础,包括心血管疾病,糖尿病溃疡,黄斑变性和癌症。血管生成在肿瘤生长和转移中起着重要作用。

MILLIPLEX®人血管生成/生长因子面板1用于同时定量人血浆、血清样品和组织/细胞裂解物和因子上清液样品中以下17种人血管生成和生长培养生物标志物的任何或全部:血管生成素-2、BMP-9、EGF、内皮糖蛋白、内皮素-1、FGF-1(酸性FGF)、FGF-2(碱性FGF)、卵泡抑素、G-CSF、HB-EGF、HGF、IL-8、瘦素、PLGF、VEGF-A、VEGF-C和VEGF-D。该试剂盒采用96孔板,包含冻干标准混合物、两个内部检测质控品,最多可测量38份样品,一式两份。

Luminex® xMAP®平台使用磁珠免疫分析格式,以实现理想的速度和灵敏度,同时定量多种分析物,从而显著提高生产力,同时节省宝贵的样本量。

面板类型:循环癌症

特異性

交叉反应性
抗体与该面板中任何其他分析物之间的交叉反应性都为无法检测或可忽略。

應用

  • 分析物:血管生成素-2、BMP-9、EGF、内皮糖蛋白、内皮素-1、FGF-1(酸性FGF)、FGF-2(碱性FGF)、卵泡抑素、G-CSF、HB-EGF、HGF、IL-8、瘦素、PLGF、VEGF-A、VEGF-C、VEGF-D
  • 推荐的样品类型:人血清、血浆、组织/细胞裂解物或培养上清液
  • 推荐的样品稀释度:每孔25 μL血浆或血清的1:3稀释液;每孔25 μL细胞培养上清液,根据需要用适当的对照培养基稀释
  • 分析运行时间:在2-8℃下过夜(16-18小时)
  • 研究类别:癌症

特點和優勢

通过在此面板中选择可用的分析物来设计多重试剂盒。

包裝

单个试剂盒即可满足您的所有需求。

儲存和穩定性

试剂盒组分建议的存储温度为2-8°C。

其他說明

灵敏度:有关单个分析物的灵敏度,请参阅试剂盒方案。

法律資訊

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

訊號詞

Danger

危險分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

標靶器官

Respiratory Tract

儲存類別代碼

10 - Combustible liquids


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Christopher A Adase et al.
The Journal of biological chemistry, 291(22), 11635-11646 (2016-04-07)
A critical function for skin is that when damaged it must simultaneously identify the nature of the injury, repair barrier function, and limit the intrusion of pathogenic organisms. These needs are carried out through the detection of damage-associated molecular patterns
Neil Patel et al.
American journal of physiology. Lung cellular and molecular physiology, 308(4), L378-L383 (2014-12-07)
Pulmonary hypertension (PH) due to abnormal pulmonary vascular development is an important determinant of illness severity in congenital diaphragmatic hernia (CDH). Vascular endothelial growth factor A (VEGFA) and placental growth factor (PLGF) may be important mediators of pulmonary vascular development
Ruijin Shao et al.
Data in brief, 6, 135-142 (2016-02-10)
In this data, non-pregnant women during the menstrual cycle, women with normal intrauterine pregnancy (IUP), and women with tubal ectopic pregnancy (EP) after informed consent were included. The serum levels of 17β-estradiol, progesterone, testosterone, beta-human chorionic gonadotropin, interleukin (IL)-1β, IL-4
Qing Xu et al.
Journal of diabetes research, 2022, 8435603-8435603 (2022-02-01)
To investigate the aqueous levels of angiogenic factors in nonproliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME) and to ascertain their association with optical coherence tomography angiography (OCTA) metrics. This study enrolled 21 NPDR eyes with DME (NPDR/DME+)
Kevin P Daly et al.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 32(1), 120-128 (2012-12-25)
Cardiac allograft vasculopathy (CAV), the major cause of late allograft loss after cardiac transplantation, results from donor-directed cellular and humoral alloimmune responses. Graft vascular endothelial cells (EC) are primary targets of these destructive responses, suggesting that factors associated with endothelial

相關內容

See how MILLIPLEX® multiplex immunoassays offer researchers the ability to simultaneously quantitate a large number of human cytokines, chemokines, and growth factors, and detect human immunoglobulins against SARS-CoV-2 antigens, to better understand the immune response to COVID-19, including cytokine storm.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務